Notice of Closed Meeting, 2437-2438 [2022-00717]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 10 / Friday, January 14, 2022 / Notices
consultancies, non-financial scientific
interests, and research grants or
contracts.
To obtain a diversity of perspectives,
AHRQ particularly encourages
nominations of women, members of
underrepresented populations, and
persons with disabilities. Interested
individuals can nominate themselves.
Organizations and individuals may
nominate one or more people qualified
for membership on the USPSTF at any
time. Individuals nominated prior to
March 15, 2021, who continue to have
interest in serving on the USPSTF
should be re-nominated.
lotter on DSK11XQN23PROD with NOTICES1
Qualification Requirements
To qualify for the USPSTF and
support its mission, an applicant or
nominee should, at a minimum,
demonstrate knowledge, expertise, and
national leadership in the following
areas:
1. The critical evaluation of research
published in peer-reviewed literature
and in the methods of evidence review;
2. Clinical prevention, health
promotion and primary health care; and
3. Implementation of evidence-based
recommendations in clinical practice
including at the clinician-patient level,
practice level, and health-system level.
Additionally, the Task Force benefits
from members with expertise in the
following areas:
D Public Health
D Health Equity and The Reduction of
Health Disparities
D Application of Science to Health
Policy
D Decision modeling
D Dissemination and Implementation
D Behavioral Medicine/Clinical Health
Psychology
D Communication of Scientific Findings
to Multiple Audiences Including
Health Care Professionals, Policy
Makers, and the General Public
Candidates with experience and skills
in any of these areas should highlight
them in their nomination materials.
Applicants must have no substantial
conflicts of interest, whether financial,
professional, or intellectual, that would
impair the scientific integrity of the
work of the USPSTF and must be
willing to complete regular conflict of
interest disclosures.
Applicants must have the ability to
work collaboratively with a team of
diverse professionals who support the
mission of the USPSTF. Applicants
must have adequate time to contribute
substantively to the work products of
the USPSTF.
VerDate Sep<11>2014
18:04 Jan 13, 2022
Jkt 256001
Nominee Selection
Nominated individuals will be
selected for the USPSTF on the basis of
how well they meet the required
qualifications and the current expertise
needs of the USPSTF. It is anticipated
that new members will be invited to
serve on the USPSTF beginning in
January, 2023. All nominated
individuals will be considered;
however, strongest consideration will be
given to individuals with demonstrated
training and expertise in the areas of
Internal Medicine, Pediatrics, and
Advanced Practice Nursing. AHRQ will
retain and may consider for future
vacancies nominations received this
year and not selected during this cycle.
Some USPSTF members without
primary health care clinical experience
may be selected based on their expertise
in methodological issues such as metaanalysis, analytic modeling, or clinical
epidemiology. For individuals with
clinical expertise in primary health care,
additional qualifications in
methodology would enhance their
candidacy.
Background
Under Title IX of the Public Health
Service Act, AHRQ is charged with
enhancing the quality, appropriateness,
and effectiveness of health care services
and access to such services. 42 U.S.C.
299(b). AHRQ accomplishes these goals
through scientific research and
promotion of improvements in clinical
practice, including clinical prevention
of diseases and other health conditions.
See 42 U.S.C. 299(b).
The USPSTF, an independent body of
experts in prevention and evidencebased medicine, works to improve the
health of all Americans by making
evidence-based recommendations about
the effectiveness of clinical preventive
services and health promotion. The
recommendations made by the USPSTF
address clinical preventive services for
adults and children, and include
screening tests, counseling services, and
preventive medications.
The USPSTF was first established in
1984 under the auspices of the U.S.
Public Health Service. Currently, the
USPSTF is convened by the Director of
AHRQ, and AHRQ provides ongoing
scientific, administrative, and
dissemination support for the USPSTF’s
operation. See 42 U.S.C. 299b–4(a)(1).
USPSTF members are invited to serve
four year terms. New members are
selected each year to replace those
members who are completing their
appointments.
The USPSTF rigorously evaluates the
effectiveness of clinical preventive
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
2437
services and formulating or updating
recommendations regarding the
appropriate provision of preventive
services. Current USPSTF
recommendations and associated
evidence reviews are available on the
internet (www.uspreventiveservices
taskforce.org).
USPSTF members meet three times a
year for two days in the Washington, DC
area or virtually if necessary. A
significant portion of the USPSTF’s
work occurs between meetings during
conference calls and via email
discussions. Member duties include
prioritizing topics, designing research
plans, reviewing and commenting on
systematic evidence reviews, discussing
evidence and making recommendations
on preventive services, reviewing
stakeholder comments, drafting final
recommendation documents, and
participating in workgroups on specific
topics and methods. Members can
expect to receive frequent emails, can
expect to participate in multiple
conference calls each month, and can
expect to have periodic interaction with
stakeholders. AHRQ estimates that
members devote approximately 200
hours a year outside of in-person
meetings to their USPSTF duties. The
members are all volunteers and do not
receive any compensation beyond
support for travel to attend the thrice
yearly meetings and trainings.
Dated: January 7, 2022.
Marquita Cullom,
Associate Director.
[FR Doc. 2022–00488 Filed 1–13–22; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
E:\FR\FM\14JAN1.SGM
14JAN1
2438
Federal Register / Vol. 87, No. 10 / Friday, January 14, 2022 / Notices
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel;
(SEP)—RFA–CK–22–005, Vector-Borne
Disease Regional Centers of Excellence.
Dates: March 17–18, 2022.
Times: 10:00 a.m.–5:00 p.m., EDT.
Place: Teleconference, Centers for
Disease Control and Prevention, Room
1080, 8 Corporate Square Boulevard,
Atlanta, GA 30329–4027.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National
Center for HIV, Viral Hepatitis, STD,
and TB Prevention, CDC, 1600 Clifton
Road NE, Mailstop US8–1, Atlanta,
Georgia 30329–4027, Telephone: (404)
718–8833, Email: GAnderson@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–00717 Filed 1–13–22; 8:45 am]
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–CE–22–008, Using Data Linkage to
Improve Our Understanding of Suicide/
Self-inflicted Injury and/or Drowning.
Date: May 24–25, 2022.
Time: 8:30 a.m.–5:30 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Mikel Walters, Ph.D., Scientific Review
Officer, National Center for Injury
Prevention and Control, CDC, 4770
Buford Highway NE, Mailstop S106–9,
Atlanta, Georgia 30341–3717,
Telephone: (404) 639–0913, Email:
MWalters@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–CE–22–007: Reduce Health
Disparities and Improve Traumatic
Brain Injury (TBI) Related Outcomes
Through the Implementation of CDC’s
Pediatric Mild TBI Guideline.
Date: June 6–7, 2022.
Time: 8:30 a.m.–5:30 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Mikel Walters, Ph.D., Scientific Review
Official, National Center for Injury
Prevention and Control, CDC, 4770
Buford Highway NE, Mailstop F–63,
Atlanta, Georgia 30341, Telephone (404)
639–0913, MWalters@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–00722 Filed 1–13–22; 8:45 am]
[FR Doc. 2022–00719 Filed 1–13–22; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
lotter on DSK11XQN23PROD with NOTICES1
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
VerDate Sep<11>2014
18:04 Jan 13, 2022
Jkt 256001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
E:\FR\FM\14JAN1.SGM
14JAN1
]]>Agencies
[Federal Register Volume 87, Number 10 (Friday, January 14, 2022)]
[Notices]
[Pages 2437-2438]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-00717]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with
[[Page 2438]]
the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel; (SEP)--RFA-CK-22-005, Vector-Borne
Disease Regional Centers of Excellence.
Dates: March 17-18, 2022.
Times: 10:00 a.m.-5:00 p.m., EDT.
Place: Teleconference, Centers for Disease Control and Prevention,
Room 1080, 8 Corporate Square Boulevard, Atlanta, GA 30329-4027.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National Center for HIV, Viral Hepatitis,
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1,
Atlanta, Georgia 30329-4027, Telephone: (404) 718-8833, Email:
[email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-00717 Filed 1-13-22; 8:45 am]
BILLING CODE 4163-18-P
